ProSomnus EVO Guided

About Prosomnus

Prosomnus is a public medical device company (NASDAQ: OSA) focused on disrupting the sleep apnea treatment market with its precision-engineered oral appliances. Founded in 2013, the company has established a significant presence, claiming hundreds of thousands of users worldwide, by addressing the critical adherence problem of traditional CPAP therapy. Its strategy hinges on a hybrid commercial model engaging both dental and medical sleep providers, supported by clinical data demonstrating strong patient preference (96% over CPAP) and a compelling economic value proposition to payers.

Therapeutic Areas

Other Obstructive Sleep Apnea (OSA) & Snoring Drugs